Skip to content

Sensorimotor Control in People With and Without Neck Pain

Analysis of Sensorimotor Control in People With and Without Neck Pain Using Inertial Sensor Technology: Study Protocol for a Longitudinal Prospective Observational Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05032911
Enrollment
100
Registered
2021-09-02
Start date
2021-10-10
Completion date
2023-02-15
Last updated
2021-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Movement Disorders, Neck Pain

Brief summary

This is a descriptive, observational, longitudinal, prospective study consecutively enrolling patients with non-specific neck pain and age-matched asymptomatic participants. The investigators will register sensorimotor control variables, including active range of motion, movement speed, acceleration, smoothness of motion, head repositioning accuracy and motion coupling patterns. These variables will be recorded by means of Inertial Measurement Unit (IMU) sensors during the following tests consecutively performed in two measuring sessions separated by 12 months: (a) kinematics of planar movements, (b) kinematics of the craniocervical flexion movement, (c) kinematics during functional tasks and (d) kinematics of task-oriented neck movements in response to visual targets.

Interventions

DIAGNOSTIC_TESTsensorimotor control analysis using inertial sensor technology

Inertial Measurement Unit (IMU) sensors will measure sensorimotor control variables including active range of motion, movement speed, acceleration, smoothness of motion, head repositioning accuracy and motion coupling patterns

Sponsors

CEU San Pablo University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Population aged between 18 and 65 years old

Exclusion criteria

* Visual impairment not corrected by the use of glasses/contact lenses * Migraine headache * Complex regional syndrome * Previous surgeries in the neck and/or head region * Sensory and/or vestibular alterations, (f) Otogenic or idiopathic vertigo/dizziness * Presence of tumors in the craniocervical region * Previous fracture in the head or neck region * Osseous deformities in the thoracic, cervical or cranial region

Design outcomes

Primary

MeasureTime frameDescription
Motion coupling patterns1 yearCalculated as the angular displacement occurring in a different anatomical plane to the one that is being tested for each of the planar movements
Movement speed1 yearExpressed as angular velocity (°/sec) in 3 full-movements (flexion-extension, lateral flexion and rotation)
Smoothness of motion1 yearexpressed as movement jerk (º/sec3)
Head repositioning accuracy1 yearCalculated as the repositioning error considering the difference between the neutral starting position and the following positions reached after the performance of any of the movements
Active range of motion1 yearExpressed as an angular displacement (°) in 3 full-movements (flexion-extension, lateral flexion and rotation)

Secondary

MeasureTime frameDescription
Fear of movement and injury1 yearMeasured using the Tampa Scale for Kinesiophobia (TSK-11). It consists of 11 questions scored from 1 to 4. Therefore, a score of 11 is the lowest possible level of kinesiphobia, while 44 is the highest.
Pain-related fear-avoidance1 yearMeasured using the Fear Avoidance Components Scale (FACS). It has 20 itemsmeasured on a 6-point Likert scale for total possible score of 100 and the lowest possible score of 0. Higher scores indicate higher levels of fear avoidance.
Physical activity level1 yearMeasured using the short version of the International Physical Activity Questionnaire (IPAQ). The score of the scale is expressed in MET level x minutes of activity/day x days per week. Levels of 3.3 METs are considered light, 4.0 METs are moderate and 8.0 METs are vigorous.

Contacts

Primary ContactAitor Martin Pintado Zugasti, PhD
martinpintado@ceu.es91 3724700

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026